Advancing Clinical Research in Long QT Syndrome

Our clinical portfolio in Long QT Syndrome (LQTS) spans both interventional and observational research. The Wave studies assess the therapeutic potential of SGK1 inhibition, while myQTwave captures the lived experience of adults with LQTS Types 2 and 3 to help inform future innovation.

Together, these programs are shaping a new era of patient-centered progress in LQTS.

Please note: Our enrolling studies are currently open only to individuals residing in the United States.